The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Xenobiotic Metabolism, Disposition, and Regulation by Receptors: From Biochemical Phenomenon to Predictors of Major Toxicities
Open accessAbstract
To commemorate the 50th anniversary of the Society of Toxicology, this special edition article reviews the history and current scope of xenobiotic metabolism and transport, with special emphasis on the discoveries and impact of selected "xenobiotic receptors." This overall research realm has witnessed dynamic development in the past 50 years, and several of the key milestone events that mark the impressive progress in these areas of toxicological sciences are highlighted. From the initial observations regarding aspects of drug metabolism dating from the mid- to late 1800's, the area of biotransformation research witnessed seminal discoveries in the mid-1900's and onward that are remarkable in retrospect, including the discovery and characterization of the phase I monooxygenases, the cytochrome P450s. Further research uncovered many aspects of the biochemistry of xenobiotic metabolism, expanding to phase II conjugation and phase III xenobiotic transport. This led to hallmark developments involving integration of genomic technologies to elucidate the basis for interindividual differences in response to xenobiotic exposures and discovery of nuclear and soluble receptor families that selectively "sense" the chemical milieu of the mammalian cell and orchestrate compensatory changes in gene expression programming to accommodate complex xenobiotic exposures. This review will briefly summarize these developments and investigate the expanding roles of xenobiotic receptor biology in the underlying basis of toxicological response to chemical agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 1×
“These factors then bind to the promoters of a rather large subset of genes termed ‘‘acute-phase,’’ such as c-reactive protein, serum amyloid A (SAA), many complement factors such as C3, and tissue plasminogen activator (Gabay and Kushner, 1999).”
BackgroundMechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164 · cited 2×
“Polyunsaturated fatty acids and fatty acid derivatives such as 15-deoxy-delta12,14-prostaglandin J2 (15-dPGJ2), 9-hydroxyoctadecadienoic acid (HODE), 13-HODE, and nitrated fatty acids can all activate PPARc and may serve as endogenous ligands (Forman et al., 1997; Keller et al., 1993; Kliewer et al., 1997; Krey et al.…”
BackgroundForman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Denison, M. S., & Nagy, S. R. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135828 · Cited by 1,895 · cited 3×
“…from https://academic.oup.com/toxsci/article-abstract/120/suppl_1/S49/1616424 by guest on 27 July 2018 The AHR is considered a promiscuous receptor that is capable of binding a large number of structurally diverse chemicals, select examples of which are shown in Figure 4 (Denison and Nagy, 2003).”
BackgroundOxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649 · cited 2×
“PAS (Per-Sim-ARNT) domain receptor (Hankinson 1995).”
BackgroundThe aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
4 Histology and Histopathology
(2015) · Burghardt’s Colposcopy and Cervical Pathology · doi:10.1055/b-0035-108581 · Cited by 1,043
Nelson, D. R. (2009) · Human Genomics · doi:10.1186/1479-7364-4-1-59 · Cited by 1,014
Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., & Kaminsky, L. S. (1982) · Biochemistry · doi:10.1021/bi00266a045 · Cited by 1,012
Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K., & Wahli, W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2160 · Cited by 948
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
Moore, L. B., Goodwin, B., Jones, S. A., Wisely, G. B., Serabjit-Singh, C. J., Willson, T. M., Collins, J. L., & Kliewer, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130155097 · Cited by 947
SXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916
Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895
Reddy, J. K., Lalvvai, N. D., & Farber, E. (1983) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448309029317 · Cited by 879
Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306981100 · Cited by 832
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B., Liddle, C., Blanchard, S. G., Willson, T. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001215200 · Cited by 815
(1994) · Pharmaceutical Design And Development · doi:10.1201/b12597-9 · Cited by 784
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Beischlag, T. V., Morales, J. L., Hollingshead, B. D., & Perdew, G. H. (2008) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v18.i3.20 · Cited by 727
Self-citationA New Cytochrome in Liver Microsomes
Omura, T., & Sato, R. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60338-2 · Cited by 684
Pigments of rat liver microsomes
Klingenberg, M. (1958) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(58)90436-3 · Cited by 664
Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., & Kliewer, S. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.638 · Cited by 654
Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., & Reddy, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7921 · Cited by 653
EVOLUTION OF THE ATP-BINDING CASSETTE (ABC) TRANSPORTER SUPERFAMILY IN VERTEBRATES
Dean, M., & Annilo, T. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162122 · Cited by 650
Structure and function of glutathione S-transferases
Wilce, M. C. J., & Parker, M. W. (1994) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(94)90086-8 · Cited by 647
DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 634
Self-citationLu, A. Y. H., & Coon, M. J. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)56992-7 · Cited by 627
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., et al. (2003) · Critical Reviews in Toxicology · doi:10.1080/713608372 · Cited by 611
Self-citationGuan, Y., Hao, C., Cha, D. R., Rao, R., Lu, W., Kohan, D. E., Magnuson, M. A., Redha, R., Zhang, Y., & Breyer, M. D. (2005) · Nature Medicine · doi:10.1038/nm1278 · Cited by 608
Gillmore, J. D., Lovat, L. B., Persey, M. R., Pepys, M. B., & Hawkins, P. N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05252-1 · Cited by 595
NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT
HESS, R., STÄUBLI, W., & RIESS, W. (1965) · Nature · doi:10.1038/208856a0 · Cited by 594
Peroxisome-proliferator-activated receptors and cancers: complex stories
Michalik, L., Desvergne, B., & Wahli, W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1254 · Cited by 573
Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y., & Kishimoto, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804231105 · Cited by 542
Veldhoen, M., Hirota, K., Christensen, J., O'Garra, A., & Stockinger, B. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081438 · Cited by 520
PPAR-γ regulates osteoclastogenesis in mice
Wan, Y., Chong, L.-W., & Evans, R. M. (2007) · Nature Medicine · doi:10.1038/nm1672 · Cited by 517
PPARδ regulates glucose metabolism and insulin sensitivity
Lee, C.-H., Olson, P., Hevener, A., Mehl, I., Chong, L.-W., Olefsky, J. M., Gonzalez, F. J., Ham, J., Kang, H., Peters, J. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511253103 · Cited by 497
Self-citationBaes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D., & Moore, D. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1544 · Cited by 494
Peters, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2029 · Cited by 479
Self-citationFujiwara, T., Yoshioka, S., Yoshioka, T., Ushiyama, I., & Horikoshi, H. (1988) · Diabetes · doi:10.2337/diab.37.11.1549 · Cited by 473
Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding
Escher, P., Braissant, O., Basu-Modak, S., Michalik, L., Wahli, W., & Desvergne, B. (2001) · Endocrinology · doi:10.1210/endo.142.10.8458 · Cited by 472
Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., & Negishi, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.1 · Cited by 466
Braissant, O., & Wahli, W. (1998) · Endocrinology · doi:10.1210/en.139.6.2748 · Cited by 454
Hepatic Dysfunction Associated with Troglitazone
Watkins, P. B., & Whitcomb, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381314 · Cited by 446
The structure of the nuclear hormone receptors
Kumar, R., & Thompson, E. B. (1999) · Steroids · doi:10.1016/s0039-128x(99)00014-8 · Cited by 435
Welch, J. S., Ricote, M., Akiyama, T. E., Gonzalez, F. J., & Glass, C. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031789100 · Cited by 429
Nitrolinoleic acid. An endogenous peroxisome proliferator-activated receptor γ ligand
Schopfer, F. J., Lin, Y., Baker, P. R. S., Cui, T., Garcia-Barrio, M., Zhang, J., Chen, K., Chen, Y. E., & Freeman, B. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408384102 · Cited by 428
CAR and PXR: The xenobiotic-sensing receptors☆
Timsit, Y. E., & Negishi, M. (2007) · Steroids · doi:10.1016/j.steroids.2006.12.006 · Cited by 423
Maglich, J. M., Parks, D. J., Moore, L. B., Collins, J. L., Goodwin, B., Billin, A. N., Stoltz, C. A., Kliewer, S. A., Lambert, M. H., Willson, T. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300138200 · Cited by 416
Evidence for a new P-450 hemoprotein in hepatic microsomes from methylcholanthrene treated rats
Sládek, N. E., & Mannering, G. J. (1966) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(66)90376-7 · Cited by 415
Pigments of rat liver microsomes
Klingenberg, M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00621-5 · Cited by 411
Berger, J., Leibowitz, M. D., Doebber, T. W., Elbrecht, A., Zhang, B., Zhou, G., Biswas, C., Cullinan, C. A., Hayes, N. S., Li, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6718 · Cited by 410
Tzameli, I., Pissios, P., Schuetz, E. G., & Moore, D. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.2951-2958.2000 · Cited by 408
Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity
Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., & Gallo, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.510 · Cited by 405
Gupta, R. A., Tan, J., Krause, W. F., Geraci, M. W., Willson, T. M., Dey, S. K., & DuBois, R. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13275 · Cited by 401
Biochimica et biophysica acta. Protein structure and molecular enzymology
ScienceDirect (2002) · Cited by 395
Transcriptional regulation of ABC drug transporters
Scotto, K. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206950 · Cited by 392
Conney, A. H., Miller, E. C., & Miller, J. A. (1956) · PubMed · Cited by 391
Acute Liver Failure in the United States
(2003) · Seminars in Liver Disease · doi:10.1055/s-2003-42641 · Cited by 387
Nutritional Regulation of Hepatic Heme Biosynthesis and Porphyria through PGC-1α
Handschin, C., Lin, J., Rhee, J., Peyer, A.-K., Chin, S., Wu, P.-H., Meyer, U. A., & Spiegelman, B. M. (2005) · Cell · doi:10.1016/j.cell.2005.06.040 · Cited by 383
Juge-Aubry, C., Pernin, A., Favez, T., Burger, A. G., Wahli, W., Meier, C. A., & Desvergne, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25252 · Cited by 378
Zhu, Y., Alvares, K., Huang, Q., Rao, M. S., & Reddy, J. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74184-2 · Cited by 374
Urquhart, B. L., Tirona, R. G., & Kim, R. B. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299930 · Cited by 373
Cloning of a Protein That Mediates Transcriptional Effects of Fatty Acids in Preadipocytes
Amri, E.-Z., Bonino, F., Ailhaud, G., Abumrad, N. A., & Grimaldi, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2367 · Cited by 368
Phenobarbital Response Elements of Cytochrome P450 Genes and Nuclear Receptors
Sueyoshi, T., & Negishi, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.123 · Cited by 362
IJpenberg, A., Jeannin, E., Wahli, W., & Desvergne, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20108 · Cited by 352
Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., & Maronpot, R. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1459 · Cited by 350
Mechanisms of Extrahepatic Tumor Induction by Peroxisome Proliferators in Male CD Rats
Biegel, L. B., Hurtt, M. E., Frame, S. R., O'Connor, J. C., & Cook, J. C. (2001) · Toxicological Sciences · doi:10.1093/toxsci/60.1.44 · Cited by 349
Reddy, J. K., & Krishnakantha, T. P. (1975) · Science · doi:10.1126/science.1198095 · Cited by 344
PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
Fajas, L., Fruchart, J.-C., & Auwerx, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01273-3 · Cited by 336
Kodama, S., Koike, C., Negishi, M., & Yamamoto, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.7931-7940.2004 · Cited by 334
Structure and Function of Sulfotransferases
Negishi, M., Pedersen, L. G., Petrotchenko, E., Shevtsov, S., Gorokhov, A., Kakuta, Y., & Pedersen, L. C. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2368 · Cited by 333
Schroeder, J. C., DiNatale, B. C., Murray, I. A., Flaveny, C. A., Liu, Q., Laurenzana, E. M., Lin, J. M., Strom, S. C., Omiecinski, C. J., Amin, S., et al. (2010) · Biochemistry · doi:10.1021/bi901786x · Cited by 330
Self-citationDioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors.
Ema, M., Ohe, N., Suzuki, M., Mimura, J., Sogawa, K., Ikawa, S., & Fujii-Kuriyama, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46990-6 · Cited by 329 · cited 2×
“Initial studies on the human AHR revealed that the human receptor contains a point mutation in the ligandbinding domain (valine 381) that lowers its ability to bind TCDD by ~10-fold compared with the Ahb allele of the mouse AHR (Ema et al., 1994; Harper et al., 1988; Ramadoss and Perdew, 2004).”
BackgroundBURGEN, A. S. V. (1971) · Nature · doi:10.1038/232587a0 · Cited by 328
Di-Poı̈, N., Tan, N. S., Michalik, L., Wahli, W., & Desvergne, B. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00646-9 · Cited by 327
Alvares, A. P., Schilling, G., Levin, W., & Kuntzman, R. G. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(67)90515-3 · Cited by 327
2.1 Å Crystal Structure of Human PXR in Complex with the St. John's Wort Compound Hyperforin,
Watkins, R. E., Maglich, J. M., Moore, L. B., Wisely, G. B., Noble, S. M., Davis-Searles, P. R., Lambert, M. H., Kliewer, S. A., & Redinbo, M. R. (2003) · Biochemistry · doi:10.1021/bi0268753 · Cited by 319
Modulation of Acetaminophen-Induced Hepatotoxicity by the Xenobiotic Receptor CAR
Zhang, J., Huang, W., Chua, S. S., Wei, P., & Moore, D. D. (2002) · Science · doi:10.1126/science.1073502 · Cited by 316
Ashby, J., Brady, A., Elcombe, C. R., Elliott, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S., & Purchase, I. F. H. (1994) · Human & Experimental Toxicology · doi:10.1177/096032719401300201 · Cited by 313
Sznaidman, M. L., Haffner, C. D., Maloney, P. R., Fivush, A., Chao, E., Goreham, D., Sierra, M. L., LeGrumelec, C., Xu, H. E., Montana, V. G., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00207-5 · Cited by 312
Metabolic Conjugation and Metabolic Hydrolysis
(1970) · Elsevier eBooks · doi:10.1016/c2013-0-10659-9 · Cited by 310
Non-carcinogenic effects of TCDD in animals
Birnbaum, L. S., & Tuomisto, J. (2000) · Food Additives & Contaminants · doi:10.1080/026520300283351 · Cited by 304
Faucette, S. R., Zhang, T.-C., Moore, R., Sueyoshi, T., Omiecinski, C. J., LeCluyse, E. L., Negishi, M., & Wang, H. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112136 · Cited by 294
Self-citationCutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
Cheng, N., He, R., Tian, J., Ye, P. P., & Ye, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.22 · Cited by 284
Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., & Moore, D. D. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0520 · Cited by 284
Differential Transactivation by Two Isoforms of the Orphan Nuclear Hormone Receptor CAR
Choi, H.-S., Chung, M., Tzameli, I., Simha, D., Lee, Y.-K., Seol, W., & Moore, D. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23565 · Cited by 279
Mode of Action in Relevance of Rodent Liver Tumors to Human Cancer Risk
Holsapple, M. P., Pitot, H. C., Cohen, S. H., Boobis, A. R., Klaunig, J. E., Pastoor, T., Dellarco, V. L., & Dragan, Y. P. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj001 · Cited by 264
PPARα: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators
Gonzalez, F. J., & Shah, Y. M. (2008) · Toxicology · doi:10.1016/j.tox.2007.09.030 · Cited by 262
Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease
Dong, B., Saha, P. K., Huang, W., Chen, W., Abu-Elheiga, L. A., Wakil, S. J., Stevens, R. D., Ilkayeva, O., Newgard, C. B., Chan, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909731106 · Cited by 260
Intrinsic Function of the Aryl Hydrocarbon (Dioxin) Receptor as a Key Factor in Female Reproduction
Baba, T., Mimura, J., Nakamura, N., Harada, N., Yamamoto, M., Morohashi, K.-I., & Fujii-Kuriyama, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10040-10051.2005 · Cited by 256
Shah, Y. M., Morimura, K., Yang, Q., Tanabe, T., Takagi, M., & Gonzalez, F. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00317-07 · Cited by 255
The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR)
Peraza, M. A., Burdick, A. D., Marin, H. E., Gonzalez, F. J., & Peters, J. M. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj062 · Cited by 254
Self-citationT0901317 is a potent PXR ligand: Implications for the biology ascribed to LXR
Mitro, N., Vargas, L., Romeo, R., Koder, A., & Saez, E. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.047 · Cited by 250
Zhang, J., Huang, W., Qatanani, M., Evans, R. M., & Moore, D. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409041200 · Cited by 246
PXR and CAR in energy metabolism
Wada, T., Gao, J., & Xie, W. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.03.003 · Cited by 242
Muller, A. J., Sharma, M. D., Chandler, P. R., DuHadaway, J. B., Everhart, M. E., Johnson, B. A., Kahler, D. J., Pihkala, J., Soler, A. P., Munn, D. H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806173105 · Cited by 240
Assem, M., Schuetz, E. G., Leggas, M., Sun, D., Yasuda, K., Reid, G., Zelcer, N., Adachi, M., Strom, S., Evans, R. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314111200 · Cited by 240
Serum amyloid A: An acute-phase protein involved in tumour pathogenesis
Malle, E., Sodin-Semrl, S., & Kovacevic, A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8321-x · Cited by 234
Gao, J., He, J., Zhai, Y., Wada, T., & Xie, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016808 · Cited by 233
Nagasawa, T., Inada, Y., Nakano, S., Tamura, T., Takahashi, T., Maruyama, K., Yamazaki, Y., Kuroda, J., & Shibata, N. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.028 · Cited by 233
Bility, M. T. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh253 · Cited by 231
A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR
Huang, W., Zhang, J., & Moore, D. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18385 · Cited by 229
Stedman, C. A. M., Liddle, C., Coulter, S. A., Sonoda, J., Alvarez, J. G. A., Moore, D. D., Evans, R. M., & Downes, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409794102 · Cited by 228
A Structural Basis for Constitutive Activity in the Human CAR/RXRα Heterodimer
Xu, R. X., Lambert, M. H., Wisely, B. B., Warren, E. N., Weinert, E. E., Waitt, G. M., Williams, J. D., Collins, J. L., Moore, L. B., Willson, T. M., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.042 · Cited by 226
Burk, O., Arnold, K. A., Nussler, A. K., Schaeffeler, E., Efimova, E., Avery, B. A., Avery, M. A., Fromm, M. F., & Eichelbaum, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009019 · Cited by 224
The Nuclear Receptor CAR Is a Regulator of Thyroid Hormone Metabolism during Caloric Restriction
Maglich, J. M., Watson, J., McMillen, P. J., Goodwin, B., Willson, T. M., & Moore, J. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313601200 · Cited by 223
Moreau, A., Vilarem, M. J., Maurel, P., & Pascussi, J. M. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700103m · Cited by 220
Ebert, B., Seidel, A., & Lampen, A. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi139 · Cited by 220
Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., & Bradfield, C. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209594200 · Cited by 215 · cited 13×
“In 1990, a receptor termed PPAR was cloned from mouse liver using the estrogen receptor DNA-binding domain as a probe (Issemann and Green, 1990).”
BackgroundInfluentialCheung, C., Akiyama, T. E., Ward, J. M., Nicol, C. J., Feigenbaum, L., Vinson, C., & Gonzalez, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0322 · Cited by 215
CYP1A Induction and Human Risk Assessment: An Evolving Tale of in Vitro and in Vivo Studies
Ma, Q., & Lu, A. Y. H. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015826 · Cited by 215
Moore, D. D., Kato, S., Xie, W., Mangelsdorf, D. J., Schmidt, D. R., Xiao, R., & Kliewer, S. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.6 · Cited by 209
PPAR gamma and human metabolic disease
Chatterjee, K. (2006) · 8th European Congress of Endocrinology incorporating the British Endocrine Societies · Cited by 209
Beischlag, T. V., & Perdew, G. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500090200 · Cited by 203
Self-citationThe nuclear receptor superfamily: a personal retrospect on the first two decades
Chambon, P. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0125 · Cited by 194
Use of the nuclear receptor PXR to predict drug interactions
Moore, J. T., & Kliewer, S. A. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00300-0 · Cited by 188
Wang, D., Wang, H., Guo, Y., Ning, W., Katkuri, S., Wahli, W., Desvergne, B., Dey, S. K., & DuBois, R. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607948103 · Cited by 182
The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems
McMillan, B. J., & Bradfield, C. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037259 · Cited by 177
Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR
Handschin, C., & Meyer, U. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.08.030 · Cited by 173
The Nuclear Xenobiotic Receptor CAR
Suino, K., Peng, L., Reynolds, R., Li, Y., Cha, J.-Y., Repa, J. J., Kliewer, S. A., & Xu, H. E. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.036 · Cited by 171
Burdick, A. D., Kim, D. J., Peraza, M. A., Gonzalez, F. J., & Peters, J. M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.07.009 · Cited by 168
Self-citationCarcinogenicity of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin in experimental models
Knerr, S., & Schrenk, D. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600006 · Cited by 168
Morimura, K., Cheung, C., Ward, J. M., Reddy, J. K., & Gonzalez, F. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi329 · Cited by 168
Lahvis, G. P., Pyzalski, R. W., Glover, E., Pitot, H. C., McElwee, M. K., & Bradfield, C. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008888 · Cited by 168
Reschly, E. J., & Krasowski, M. D. (2006) · Current Drug Metabolism · doi:10.2174/138920006776873526 · Cited by 166
Role of the Constitutive Androstane Receptor in Xenobiotic-Induced Thyroid Hormone Metabolism
Qatanani, M., Zhang, J., & Moore, D. D. (2005) · Endocrinology · doi:10.1210/en.2004-1350 · Cited by 166
Idiosyncratic Liver Injury: Challenges and Approaches
Watkins, P. B. (2005) · Toxicologic Pathology · doi:10.1080/01926230590888306 · Cited by 166
Chang, T. K. H., & Waxman, D. J. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600569828 · Cited by 160
Trottier, E., Belzil, A., Stoltz, C., & Anderson, A. (1995) · Gene · doi:10.1016/0378-1119(94)00916-g · Cited by 160
The Roles of Nuclear Receptors CAR and PXR in Hepatic Energy Metabolism
Konno, Y., Negishi, M., & Kodama, S. (2008) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.23.8 · Cited by 160
Köhle, C., & Bock, K. W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.020 · Cited by 157
Ross, J., Plummer, S. M., Rode, A., Scheer, N., Bower, C. C., Vogel, O., Henderson, C. J., Wolf, C. R., & Elcombe, C. R. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq118 · Cited by 156
Williams, R. T. (1959) · Chapman & Hall eBooks · Cited by 155
Reddy, J. K., Rao, M. S., & Moody, D. E. (1976) · PubMed · Cited by 152
Girroir, E. E., Hollingshead, H. E., He, P., Zhu, B., Perdew, G. H., & Peters, J. M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.086 · Cited by 150
Self-citationWaller, C. L., & McKinney, J. D. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00048a005 · Cited by 150
PPARβ/δ selectively induces differentiation and inhibits cell proliferation
Kim, D. J., Bility, M. T., Billin, A. N., Willson, T. M., Gonzalez, F. J., & Peters, J. M. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401713 · Cited by 149
Self-citationGao, J., & Xie, W. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035568 · Cited by 146
Goyak, K. O., Page, J. L., Johnson, M. C., Zarbl, H., Strom, S. C., & Omiecinski, C. J. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.03.032 · Cited by 146
Self-citationBarbier, O., Durán-Sandoval, D., Pineda‐Torra, I., Kosykh, V., Fruchart, J., & Staels, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305361200 · Cited by 145
Effects of Aryl Hydrocarbon Receptor Signaling on the Modulation of Th1/Th2 Balance
Negishi, T., Kato, Y., Ooneda, O., Mimura, J., Takada, T., Mochizuki, H., Yamamoto, M. P., Fujii‐Kuriyama, Y., & Furusako, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7348 · Cited by 143
Scheer, N., Ross, J., Rode, A., Zevnik, B., Sandra, N., Faust, N., & Wolf, C. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35483 · Cited by 142
Swales, K. E., & Negishi, M. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0397 · Cited by 142
Characterization of a Phenobarbital-responsive Enhancer Module in Mouse P450 Cyp2b10 Gene
Honkakoski, P., & Negishi, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14943 · Cited by 142
Ligand Activation of Peroxisome Proliferator–Activated Receptor β Inhibits Colon Carcinogenesis
Marin, H. E., Peraza, M. A., Billin, A. N., Willson, T. M., Ward, J. M., Kennett, M. J., Gonzalez, F. J., & Peters, J. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4277 · Cited by 140
Self-citationKumar, M. B., & Perdew, G. H. (1999) · Europe PMC (PubMed Central) · Cited by 140
Self-citationBunger, M. K., Glover, E., Moran, S. M., Walisser, J. A., Lahvis, G. P., Hsu, E. L., & Bradfield, C. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn149 · Cited by 139
Mutoh, S., Osabe, M., Inoue, K., Moore, R., Pedersen, L. G., Perera, L., Rebolloso, Y. D., Sueyoshi, T., & Negishi, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.048108 · Cited by 139
Arylamine N-acetyltransferases: Structural and functional implications of polymorphisms
Sim, E., Lack, N. A., Wang, C.-J., Long, H., Westwood, I. M., Fullam, E., & Kawamura, A. (2008) · Toxicology · doi:10.1016/j.tox.2008.08.022 · Cited by 138
Troglitazone and liver injury: In search of answers†
Chojkier, M. (2005) · Hepatology · doi:10.1002/hep.20567 · Cited by 137
Alternatively spliced isoforms of the human constitutive androstane receptor
Auerbach, S. S., Ramsden, R., Stoner, M. A., Verlinde, C., Hassett, C., & Omiecinski, C. J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg419 · Cited by 137
Self-citationLee, M., Yoo, S., Cho, C., Suh, P., Kim, W., & Ryu, S. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5585 · Cited by 131
Peters, J. M., Hollingshead, H. E., & Gonzalez, F. J. (2008) · Clinical Science · doi:10.1042/cs20080022 · Cited by 129
Self-citationAdverse Health Effects in Humans Exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)
Pelclová, D., Urban, P., Preiss, J., Lukáš, E., Fenclová, Z., Navrátil, T., Dubská, Z., & Šenholdová, Z. (2006) · Reviews on Environmental Health · doi:10.1515/reveh.2006.21.2.119 · Cited by 128
Ligand Selectivity and Gene Regulation by the Human Aryl Hydrocarbon Receptor in Transgenic Mice
Flaveny, C. A., Murray, I. A., Chiaro, C. R., & Perdew, G. H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.054825 · Cited by 124
Self-citationDrug Uptake Systems in Liver and Kidney: A Historic Perspective
Hagenbuch, B. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.235 · Cited by 123
Ramadoss, P., & Perdew, G. H. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.129 · Cited by 121
Self-citationRat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding
Escher, P. (2001) · Endocrinology · doi:10.1210/en.142.10.4195 · Cited by 118
DiNatale, B. C., Schroeder, J. C., Francey, L. J., Kusnadi, A. R., & Perdew, G. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118570 · Cited by 117
Self-citationFang, H.-L., Strom, S. C., Cai, H., Falany, C. N., Kocarek, T. A., & Runge‐Morris, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005389 · Cited by 112
Huang, W., Zhang, J., Wei, P., Schrader, W. T., & Moore, D. D. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0046 · Cited by 110
Peters, J. M., & Gonzalez, F. J. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.06.002 · Cited by 110
Self-citationCigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway
Kitamura, M., & Kasai, A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.11.015 · Cited by 110
Gillner, M., Bergman, J., Cambillau, C., Alexandersson, M., Fernström, B., & Gustafsson, J. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13174-x · Cited by 110
Villano, C. M., Murphy, K. A., Akintobi, A., & WHITE, L. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.05.001 · Cited by 108
Evidence for Ligand-Mediated Selective Modulation of Aryl Hydrocarbon Receptor Activity
Murray, I. A., Morales, J. L., Flaveny, C. A., DiNatale, B. C., Chiaro, C. R., Gowda, K., Amin, S., & Perdew, G. H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.061788 · Cited by 104
Self-citationPatel, R. D., Murray, I. A., Flaveny, C. A., Kusnadi, A. R., & Perdew, G. H. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.24 · Cited by 103
Self-citationAuerbach, S. S., Stoner, M. A., Su, S., & Omiecinski, C. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013417 · Cited by 101
Self-citationMyotoxicity associated with lipid-lowering drugs
Baer, A. N., & Wortmann, R. L. (2006) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328010c559 · Cited by 100
Shan, W., Nicol, C. J. B., Ito, S., Bility, M. T., Kennett, M. J., Ward, J. M., Gonzalez, F. J., & Peters, J. M. (2007) · Hepatology · doi:10.1002/hep.21925 · Cited by 99
Self-citationShan, W., Palkar, P. S., Murray, I. A., McDevitt, E. I., Kennett, M. J., Kang, B. H., Isom, H. C., Perdew, G. H., Gonzalez, F. J., & Peters, J. M. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn142 · Cited by 97 · cited 1×
“This has been observed in a number of models including nonalcoholic steatohepatitis and chemically induced liver toxicity (Nagasawa et al., 2006; Shan et al., 2008a,b).”
BackgroundSelf-citationCarvajal-González, J. M., Mulero‐Navarro, S., Román, Á., Sauzeau, V., Merino, J. M., Bustelo, X. R., & Fernández‐Salguero, P. M. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-05-0451 · Cited by 96
Expression and Activity of Aryl Hydrocarbon Receptors in Development and Cancer
Gasiewicz, T. A., Henry, E. C., & Collins, L. L. (2008) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v18.i4.10 · Cited by 94
Breaking old paradigms: Th17 cells in autoimmune arthritis
Peck, A., & Mellins, E. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.03.522 · Cited by 94
Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity
Bui, L. C., Tomkiewicz, C., Chevallier, A., Pierre, S., Bats, A., Mota, S. I., Raingeaud, J., Pierre, J., Diry, M., Transy, C., et al. (2009) · Oncogene · doi:10.1038/onc.2009.224 · Cited by 94
Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor
Ikuta, T., & Kawajiri, K. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.08.002 · Cited by 93
Enzyme Inducers Improve Insulin Sensitivity in Non-insulin-dependent Diabetic Subjects
Lahtela, J. T., Arranto, A. J., & Sotaniemi, E. A. (1985) · Diabetes · doi:10.2337/diab.34.9.911 · Cited by 92
Naruhn, S., Meißner, W., Adhikary, T., Kaddatz, K., Klein, T., Watzer, B., Müller‐Brüsselbach, S., & Müller, R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.060541 · Cited by 92
Burdick, A. D., Bility, M. T., Girroir, E. E., Billin, A. N., Willson, T. M., Gonzalez, F. J., & Peters, J. M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.007 · Cited by 91
Self-citation
Cited by
RETRACTED: Quercetin: A flavonol with multifaceted therapeutic applications?
D'Andrea, G. (2015) · Fitoterapia · doi:10.1016/j.fitote.2015.09.018 · Cited by 721
RetractedEscher, B. I., Allinson, M., Altenburger, R., Bain, P. A., Balaguer, P., Busch, W., Crago, J., Denslow, N. D., Dopp, E., Hilscherova, K., et al. (2014) · Environmental Science & Technology · doi:10.1021/es403899t · Cited by 457
Synergistic Effects of Heavy Metals and Pesticides in Living Systems
Singh, N., Gupta, V. K., Kumar, A., & Sharma, B. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00070 · Cited by 267
Elcombe, C. R., Peffer, R. C., Wolf, D. C., Bailey, J., Bars, R., Bell, D., Cattley, R. C., Ferguson, S. S., Geter, D., Goetz, A., et al. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.835786 · Cited by 265
Self-citationEndogenous and exogenous mediators of quercetin bioavailability
Guo, Y., & Bruno, R. S. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.10.008 · Cited by 256
Metadata
- Authors
- Omiecinski, C. J., Vanden Heuvel, J. P., Perdew, G. H., & Peters, J. M.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-08
- Volume
- 120
- Issue
- Supplement 1
- Pages
- S49-S75
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2130448354
- Cited by
- 369
- References
- 249
- FWCI
- 15.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.